4.5 Article Proceedings Paper

Ferrocene-indole hybrids for cancer and malaria therapy

Journal

JOURNAL OF ORGANOMETALLIC CHEMISTRY
Volume 696, Issue 5, Pages 1011-1017

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.jorganchem.2010.11.021

Keywords

Cancer; Malaria; Hybrid drug; Indole; Ferrocene

Funding

  1. Ministry of Science and Innovation, Spain [CTQ2009-07021/BQU, CTQ2009-11501]
  2. AGAUR, Generalitat de Catalunya [2009-SGR-1111]
  3. Ministere de l'Enseignement Superieur

Ask authors/readers for more resources

We report the synthesis, characterization, and cytotoxic and antimalarial activity of ferrocene-indole hybrids 8-14. The 2-phenylindole scaffold was chosen because of its potent antimitotic activity and ferrocene was chosen following the development of ferrocifens, ferrocene derivatives of tamoxifen, which are prototypes of a new family of organometallic anti-estrogens. Ferrocene-indole hybrids 8-14 and their corresponding organic analogues 1-7 showed only moderate antimalarial activities, while ferrocene-indole hybrids 11 and 12 showed excellent in vitro activities against the A549 human carcinoma cell line, with IC50 values of 5 and 7 mu M respectively. These ferrocene-indole hybrids were up to 25-fold more potent as cytotoxic agents than their purely organic analogues. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available